Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release

Neuropharmacology

Volumn 54, Issue 1, 2008, Pages 58-67

  Hashimotodani, Yuki ^a   Ohno Shosaku, Takako ^b   Maejima, Takashi ^c   Fukami, Kiyoko ^d   Kano, Masanobu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^d TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

2 Arachidonoylglycerol; CB1 cannabinoid receptor; Depolarization induced suppression of inhibition; Diacylglycerol lipase; Tetrahydrolipstatin

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,6 HEXAMETHYLENEDICARBAMIC ACID BIS(CYCLOHEXANONE OXIME) ESTER; 2 ARACHIDONOYLGLYCEROL; DIACYLGLYCEROL KINASE; ENDOCANNABINOID; ET 18; LIPOPROTEIN LIPASE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROPRANOLOL DERIVATIVE; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; MOUSE; NERVE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; ARACHIDONIC ACIDS; CALCIUM; CELLS, CULTURED; ELECTRIC STIMULATION; ENDOCANNABINOIDS; ENZYME INHIBITORS; GLYCERIDES; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIALS; LIPOPROTEIN LIPASE; MEMBRANE POTENTIALS; MICE; MICE, KNOCKOUT; NEURONS; PATCH-CLAMP TECHNIQUES; PHOSPHOLIPASE C DELTA; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 37348999202     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.06.002     Document Type: Article

References (51)

1. Alger B.E. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog. Neurobiol. 68 (2002) 247-286
2. 2+ ion concentrations. Biochem. J. 327 Pt. 2 (1997) 545-552
3. Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A., Matias I., Schiano-Moriello A., Paul P., Williams E.J., Gangadharan U., Hobbs C., Di Marzo V., and Doherty P. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163 (2003) 463-468
4. Bisogno T., Ligresti A., and Di Marzo V. The endocannabinoid signalling system: biochemical aspects. Pharmacol. Biochem. Behav. 81 (2005) 224-238
5. Bisogno T., Melck D., De Petrocellis L., and Di Marzo V. Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J. Neurochem. 72 (1999) 2113-2119
6. Brose N., and Rosenmund C. Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters. J. Cell Sci. 115 (2002) 4399-4411
7. Carrier E.J., Kearn C.S., Barkmeier A.J., Breese N.M., Yang W., Nithipatikom K., Pfister S.L., Campbell W.B., and Hillard C.J. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol. Pharmacol. 65 (2004) 999-1007
8. Chevaleyre V., and Castillo P.E. Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38 (2003) 461-472
9. Chevaleyre V., Takahashi K.A., and Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 29 (2006) 37-76
10. Cockcroft S. The latest phospholipase C, PLCη, is implicated in neuronal function. Trends Biochem. Sci. 31 (2006) 4-7
11. Delmas P., and Brown D.A. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat. Rev. Neurosci. 6 (2005) 850-862
12. Edwards D.A., Kim J., and Alger B.E. Multiple mechanisms of endocannabinoid response initiation in hippocampus. J. Neurophysiol. 95 (2006) 67-75
13. Fukami K., Nakao K., Inoue T., Kataoka Y., Kurokawa M., Fissore R.A., Nakamura K., Katsuki M., Mikoshiba K., Yoshida N., and Takenawa T. Requirement of phospholipase Cδ4 for the zona pellucida-induced acrosome reaction. Science 292 (2001) 920-923
14. 3-mediated indirect suppression through endocannabinoid signalling. Eur. J. Neurosci. 19 (2004) 2682-2692
15. Haj-Dahmane S., and Shen R.Y. The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling. J. Neurosci. 25 (2005) 896-905
16. 2+ dependency for triggering retrograde endocannabinoid signal. Neuron 45 (2005) 257-268
17. Hashimotodani Y., Ohno-Shosaku T., and Kano M. Endocannabinoids and synaptic function in the CNS. Neuroscientist 13 (2007) 127-137
18. Hashimotodani Y., Ohno-Shosaku T., and Kano M. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J. Neurosci. 27 (2007) 1211-1219
19. 2+ requirement, and regulation of M current. J. Gen. Physiol. 126 (2005) 243-262
20. Hwang J.I., Oh Y.S., Shin K.J., Kim H., Ryu S.H., and Suh P.G. Molecular cloning and characterization of a novel phospholipase C, PLC-η. Biochem. J. 389 (2005) 181-186
21. Irino Y., Cho H., Nakamura Y., Nakahara M., Furutani M., Suh P.G., Takenawa T., and Fukami K. Phospholipase C δ-type consists of three isozymes: bovine PLCδ2 is a homologue of human/mouse PLCδ4. Biochem. Biophys. Res. Commun. 320 (2004) 537-543
22. Jung K.M., Mangieri R., Stapleton C., Kim J., Fegley D., Wallace M., Mackie K., and Piomelli D. Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol. Pharmacol. 68 (2005) 1196-1202
23. Kim J., and Alger B.E. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat. Neurosci. 7 (2004) 697-698
24. Kim Y.H., Park T.J., Lee Y.H., Baek K.J., Suh P.G., Ryu S.H., and Kim K.T. Phospholipase C-δ1 is activated by capacitative calcium entry that follows phospholipase C-β activation upon bradykinin stimulation. J. Biol. Chem. 274 (1999) 26127-26134
25. Kreitzer A.C., and Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29 (2001) 717-727
26. Lee S.B., and Rhee S.G. Molecular cloning, splice variants, expression, and purification of phospholipase C-δ 4. J. Biol. Chem. 271 (1996) 25-31
27. Lee W.K., Kim J.K., Seo M.S., Cha J.H., Lee K.J., Rha H.K., Min D.S., Jo Y.H., and Lee K.H. Molecular cloning and expression analysis of a mouse phospholipase C-δ1. Biochem. Biophys. Res. Commun. 261 (1999) 393-399
28. 2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cβ4 signaling cascade in the cerebellum. J. Neurosci. 25 (2005) 6826-6835
29. Makriyannis A., Guo J., and Tian X. Albumin enhances the diffusion of lipophilic drugs into the membrane bilayer. Life Sci. 77 (2005) 1605-1611
30. Melis M., Perra S., Muntoni A.L., Pillolla G., Lutz B., Marsicano G., Di Marzo V., Gessa G.L., and Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J. Neurosci. 24 (2004) 10707-10715
31. Nakahara M., Shimozawa M., Nakamura Y., Irino Y., Morita M., Kudo Y., and Fukami K. A novel phospholipase C, PLCη2, is a neuron-specific isozyme. J. Biol. Chem. 280 (2005) 29128-29134
32. Nakamura Y., Fukami K., Yu H., Takenaka K., Kataoka Y., Shirakata Y., Nishikawa S., Hashimoto K., Yoshida N., and Takenawa T. Phospholipase Cδ1 is required for skin stem cell lineage commitment. EMBO J. 22 (2003) 2981-2991
33. Nakamura Y., Hamada Y., Fujiwara T., Enomoto H., Hiroe T., Tanaka S., Nose M., Nakahara M., Yoshida N., Takenawa T., and Fukami K. Phospholipase C-δ1 and -δ3 are essential in the trophoblast for placental development. Mol. Cell Biol. 25 (2005) 10979-10988
34. Ochocka A.M., and Pawelczyk T. Isozymes delta of phosphoinositide-specific phospholipase C and their role in signal transduction in the cell. Acta Biochim. Pol. 50 (2003) 1097-1110
35. Ohno-Shosaku T., Maejima T., and Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29 (2001) 729-738
36. 2+-antagonist. Brain Res. 706 (1996) 289-292
37. 1 receptor activity in rat brain cryosections by functional autoradiography. J. Neurochem. 101 (2007) 972-981
38. Pawelczyk T., and Matecki A. Localization of phospholipase C δ3 in the cell and regulation of its activity by phospholipids and calcium. Eur. J. Biochem. 257 (1998) 169-177
39. Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4 (2003) 873-884
40. Rebecchi M.J., and Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 80 (2000) 1291-1335
41. Safo P.K., and Regehr W.G. Endocannabinoids control the induction of cerebellar LTD. Neuron 48 (2005) 647-659
42. Sekar M.C., Dickinson K.E., Pruitt R.E., Hirschowitz B.I., and Hokin L.E. Muscarinic receptor antagonist activity of diacylglycerol lipase and kinase inhibitors. Biochem. Pharmacol. 39 (1990) 2069-2073
43. Silinsky E.M., and Searl T.J. Phorbol esters and neurotransmitter release: more than just protein kinase C?. Br. J. Pharmacol. 138 (2003) 1191-1201
44. Stella N., Schweitzer P., and Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 (1997) 773-778
45. Straiker A., and Mackie K. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J. Physiol. 569 (2005) 501-517
46. Straiker A., and Mackie K. Metabotropic suppression of excitation in murine autaptic hippocampal neurons. J. Physiol. 578 (2007) 773-785
47. Sugiura T., Kishimoto S., Oka S., and Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res. 45 (2006) 405-446
48. Szabo B., Urbanski M.J., Bisogno T., Di Marzo V., Mendiguren A., Baer W.U., and Freiman I. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J. Physiol. 577 (2006) 263-280
49. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M., and Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 27 (2007) 3663-3676
50. Varro A., Lathrop D.A., and Surawicz B. Effects of propranolol on premature action potentials in canine Purkinje and ventricular muscle. J. Cardiovasc. Pharmacol. 16 (1990) 757-763
51. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 (2001) 588-592